Related references
Note: Only part of the references are listed.Feasibility of NIH consensus criteria for chronic graft-versus-host disease
B-S Cho et al.
LEUKEMIA (2009)
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease
Mary E. D. Flowers et al.
BLOOD (2008)
Phase II study of Pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease
David A. Jacobsohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease
Silvia Svegliati et al.
BLOOD (2007)
Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic sclerosis - A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
Christopher P. Denton et al.
ARTHRITIS AND RHEUMATISM (2007)
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis
Joerg H. W. Distler et al.
ARTHRITIS AND RHEUMATISM (2007)
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Brian J. Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Rituximab for steroid-refractory chronic graft-versus-host disease
Corey Cutler et al.
BLOOD (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of clinical trials working group report
PJ Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Medical progress: Hematopoietic stem-cell transplantation
EA Copelan
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD
DR Couriel et al.
BLOOD (2006)
Ancillary therapy and supportive care of chronic graft-versus-host disease:: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease:: V.: Ancillary Therapy and Supportive Care Working Group report
D Couriel et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response Criteria Working Group report
SZ Pavletic et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis
A Abdollahi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner
R Seggewiss et al.
BLOOD (2005)
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease
LJ Johnston et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease
JH Antin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Regulation of PDGF and its receptors in fibrotic diseases
JC Bonner
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant
JG Kim et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone
S Koc et al.
BLOOD (2002)
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
C Vitali et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease
M Arora et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)